講者
藉邀請國際知名的思覺失調症（schizophrenia）研究學者Distinguished Professor, Dr. Anthony A Grace (University of Pittsburgh) ，憂鬱症（depression）研究學者Professor and Chairman, Dr. Alan Frazer (University of Texas Health Science Center at San Antonio)，及成癮性藥物（drug addiction）研究學者 Dr. Stan Floresco （University of British Columbia）在研討會中進行專題演講，並敬邀國內北中南年輕一輩相關研究者（台大心理系：賴文崧副教授，政大神經科學所：廖文霖副教授，成大心理系：胡書榕副教授，清大系統神經科學所，張鈞惠助理教授）做專題報告，以期有機會提高國內此領域研究的國際能見度，促進學術討論及交流，並嘉惠有興趣的學子們對此領域的入門，了解，與研究。
Dr. Anthony A Grace
Distinguished Professor of Neuroscience
Professor of Psychiatry and Psychology
University of Pittsburgh, USA
Dr. Grace is a Distinguished Professor of Neuroscience, and Professor of Psychiatry and Psychology at the University of Pittsburgh. He has published more than 275 journal articles and chapters that have been very well-cited, yielding an H index of 89. He has received numerous awards for his research, including a MERIT award from NIMH, Lilly Basic Scientist Award and Janssen Schizophrenia Research Award from CINP, the Julius Axelrod Mentor Award and Daniel H. Efron Award from the ACNP, Outstanding Basic Science Research Award from SIRS, Gold Medal Award for Translational Research from Society of Biological Psychiatry, and election to Fellow of the AAAS, among other honors and recognitions.
Dr. Wen-Sung Lai
（賴文崧）
Associate Professor of Psychology
National Taiwan University, TAIWAN
My laboratory, Laboratory of Integrated Neuroscience and Ethology (LINE), is a multi-disciplinary research laboratory which emphasizes the integrative understanding of the links between brain/mind and behaviors from multi-disciplinary approaches. We are interested in investigating the psychobiology of the mind from abnormal and normal approaches. Our current research interests mainly focus on 4 lines of studies. (1) Basic: To study mouse models of psychiatric disorders and the possible role of AKT1 and other schizophrenia candidate genes (e.g., NRG1) in the pathogenesis of schizophrenia. (2) Advance: To investigate higher cognitive functions and reward-based decision making in both mice and humans. (3) Application: Preclinical evaluation of potential drugs for the treatment of schizophrenia and psychiatry disorders. (4) To study social neuroscience and the neural basis of social learning and memory using hamsters as a model.
Dr. Sherry Shu-Jung Hu
（胡書榕）
Associate Professor of Psychology
National Cheng Kung University, TAIWAN
The Cannabinoid Signaling Laboratory is launched in the Department of Psychology at National Cheng Kung University, Tainan, Taiwan since 2011. Cannabinoids, as a prevalent drug of abuse, strongly influence our mind, brain and behavior via the endocannabinoid system in our body. The endocannabinoid system consists of cannabinoid receptors, endocannabinoids, and the biosynthetic and degradative enzymes, which modulates a diverse set of functions such as pain, vision, learning and memory, substance abuse, appetite regulation, mood, and vascular tone. By using molecular, pharmacological, biochemical and animal behavioral approaches, our lab aims to elucidate the role of the endocannabinoid system in several pathological conditions such as abused drug-associated memory, olfactory deficit, pain and glaucoma, etc. Our ultimate goal is to identify the cannabinoid-based therapeutic intervention strategies for different psychiatric disorders.
Dr. Alan Frazer
Professor of Pharmacology and Psychiatry
Chair of Pharmacology
University of Texas Health Science Center at San Antonio, USA
Dr. Frazer is a member of numerous societies including the American Society of Pharmacology and Experimental Therapeutics, the American College of Neuropsychopharmacology (of which he is the President-Elect), the International College of Neuropsychopharmacology (CINP), of which he is a Councillor, and the Society of Neuroscience. He has been awarded a Merit Award from NIH and has been a Career Scientist of the Department of Veterans Affairs. He is currently the Editor-in-Chief of the International Journal of Neuropsychopharmacology, the official publication of the CINP. He has published more than 200 review and journal articles.
Dr. Stan Floresco
Professor of Psychology
University of British Columbia, Canada
Dr. Floresco research focuses on neural circuits related to the dopamine system that facilitate executive functioning such as cognitive flexibility and cost/benefit decision making, and how dysfunction in these circuits relates to disorders such as schizophrenia, drug addiction and depression. He has shown excellent productivity in terms of research and disseminating their findings, publishing nearly 100 papers in peer reviewed journals. Throughout his career, he has been successful in obtaining salary and research funding from federal and international scientific funding agencies. Since taking up his faculty position, he has received numerous competitive research and salary grants, including 3 concurrent CIHR grants as a sole PI and an NSERC grant. His studies have been well cited by others in the community. Dr. Floresco has been invited repeatedly by academic and industry colleagues to present their findings, and has received multiple awards from scientific colleges and UBC for his work. Furthermore, his research has also attracted interest from the pharmaceutical industry, and he has served as a consultant and received research funding from a number of pharmaceutical companies, including Pfizer.
Dr. Wenlin Liao
（廖文霖）
Associate Professor of Neuroscience
National Cheng Chi University, TAIWAN
My laboratory is interested in understanding the pathogenic mechanisms underlying neurodevelopmental disorders. Using mouse as a model system, we have been taking molecular, cellular, physiological and behavioral approaches to dissect the neural circuit basis of psychomotor dysfunction in Rett syndrome and CDKL5 disorder, two monogenic disorders sharing features with autism. We found that MeCP2 (methyl-CpG binding protein 2), mutations of which cause Rett syndrome, and CDKL5 (cyclin-dependent kinase-like 5) regulate converging pathways on dopamine in the striatum for psychomotor control in opposite direction. Our goal is to uncover novel therapeutic strategies to treat neurodevelopmental disorders.
Dr. Chun-hui Chang
（張鈞惠）
Assistant Professor of Institute of Systems Neuroscience
National Tsing Hua University, TAIWAN
The Chang Lab is launched in Institute of Systems Neuroscience at National Tsing Hua University on September, 2015. We use multiple approaches to study the extended fear circuitry in behaving rats, including lesion, pharmacology, pharmacogenetics, and functional tracing. We also use in vivo electrophysiology to look into interactions among brain structures at the circuitry level. The long-term goal is to understand 1) the neural basis of fear learning, memory, and expression, 2) the interactive brain information processing, 3) the adaptive behavioral strategies, and 4) how stress impacts the modulation process.